While nausea, vomiting, and diarrhea are common with semaglutide therapy, severe or persistent symptomsparticularly if they differ from your usual experienceshould be evaluated
They also carry a boxed warning about thyroid C-cell tumor risk and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
J., Goverse, G., Vinuesa, C
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information
The challenge is that BPC-157 information online is a mess Reddit threads, YouTube speculation, and supplement-company copy that contradict each other
However, the extent of coverage can vary based on your specific plan